CMS last week signaled plans to revisit an underused tool for gathering clinical evidence on medical technologies with the opening of a public comment period on coverage with evidence development.
Under coverage with evidence, or CED, CMS provides reimbursement for services on the condition that additional data is collected via patient participation in a registry or clinical trial